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Abstract
Background: Hypertensive disorders in pregnancy are one of the most serious complications and their early diagnosis is one of
the most important goals of prenatal care.
Objectives: The objective of this study was to determine the association of first trimester Hemoglobin (Hb) and Hematocrit (Hct)
with preeclampsia.
PatientsandMethods: This descriptive-analytic, prospective study was performed on 1376, less than 12 weeks of gestation, singleton
pregnancies, visited for their prenatal care in health and medical clinics of the Qazvin province during years 2013 and 2014. At
first, demographic data were recorded in a questionnaire and then all pregnant cases were referred to one of the three reference
laboratories for their first trimester routine tests. After hemoglobin and hematocrit date collection, women were categorized in
three groups: Hb < 11, Hb≥ 12.49 and 11≤Hb < 12.49, and based on Hct, two groups: Hct < 38% and Hct≥ 38. The analysis was done
byχ2 (chi-square) and t-test with SPSS 16. Receiver operator characteristics (ROC) curve and Youden’s index were utilized for finding
the optimum cut off for each. P values of < 0.05 were considered significant.
Results: Preeclampsia incidence was 5.1% in our study. Mean Hb was 12.38 ± 1.69 g/dL in the preeclampsia group and 11.8 ± 1.18
in the non-preeclampsia group, and mean Hct was 37.74± 5.15% in the preeclampsia group and 35.45± 3.58% in the preeclampsia
group and 35.45± 3.58% in the non-preeclampsia group, (P = 0.016) (P = 0.001). Furthermore, 43 out of 68 patients with preeclampsia
(10.9%) had high hemoglobin (Hb≥ 12.5 g/dL). We found a significant association between the 1st trimester Hb, Hct and preeclampsia
(P < 0.001, P < 0.001). Assessed relative risk in high Hb group was 5.82 (3.14 - 10.18: CI 95%), and likewise 7.41 in high Hct group (Hct >
38%) (4.41 - 12.044: CI 95%). According to Youden’s Index, optimum cut-off for 1st trimester Hb was 12.65 and for Hct, this was 38.05%.
Conclusions: The association of the 1st trimester high Hb and Hct with preeclampsia was revealed in this study, therefore it could
be used as a prediction factor for early preeclampsia diagnosis.
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1. Background
Hypertensive disorders complicate 5% - 10% of all
pregnancies, and together they are one member of the
deadly triad-along with hemorrhage and infection that
contributes greatly to maternal morbidity and mortality (1,
2). Annual maternal mortality from preeclampsia is 75000,
the etiology of which has remained unresolved in spite of
intensive research (3). The world health organization re-
ported that 16% of maternal deaths have been due to hyper-
tensive disorders in developed countries (4). Preeclamp-
sia universal prevalence is 5% - 7% and up to 20% in devel-
oped countries (5). The incidence is markedly influenced
by race and ethnicity and thus by genetic predisposition
(1). Other factors include environmental, socioeconomic
and seasonal influences (6). The prevalence is reported
6.5% in Iran (7-9). The incidence of preeclampsia was 5% in
white, 9% in Hispanic and 11% in African American women
as indicated by a study in 2012 (10). The incidence was re-
ported as 3% - 10% among nulliparous populations whereas
variable in multiparas by a study in 2014 (11). The etiology
has remained unsolved, although the latent pathophysio-
logic changes are subtle at first, then speed up along preg-
nancy and finally present clinically (1). In spite of its un-
known etiology, documents have demonstrated the possi-
bility of angiogenic factors imbalance (12, 13). Preeclamp-
sia is a multisystemic conceptual disorder with endothe-
lial dysfunction (14). Increased blood concentration, has
been a diagnostic clue for preeclampsia diagnosis for a
century (15). Endothelial cell activation causes interstitial
plasma leakage and generalized vasoconstriction through
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which, blood concentration increases (1). There are limited
studies, with different results and restrictions about the
association of 1st trimester blood indices and preeclamp-
sia. On the other hand, early diagnosis is an important
goal in prenatal care, however there is no reliable predic-
tive test. The variability of clinical, biophysical and bio-
chemical predictive tests for preeclampsia, reflects their
low accuracy. Phaloprakarn’s study, revealed 1st trimester
Hb and Hct increase in preeclampsia (16). Another study in
2013, demonstrated the association of 1st trimester Hb and
Hct with preeclampsia incidence (17). However, there are
some other researches, presenting this association with 1st
trimester anemia and attenuated Hb and Hct (18, 19). Other
researches have assessed this relationship during the 2nd
and 3rd trimester of gestation (20, 21).
2. Objectives
There is no reliable, accurate and cost-benefit screen-
ing test for preeclampsia and the vast amount of strategies
for its prevention or modification have not been effective.
Since pregnancy volume expansion and ferrous supple-
mentation have not begun in the 1st trimester, Hb level in
this time is more reliable than in the 2nd and 3rd trimester.
Likewise, a low cost, accessible and easy test like complete
blood count (CBC) is necessary in the 1st trimester. Therefor
we would rather study the association and predictive value
of 1st trimester Hb and Hct for preeclampsia prediction.
3. Patients andMethods
This descriptive-analytic and prospective cohort study
was performed from September 2013 to May 2014 at five
medical centers of the Qazvin province. Sample size was as-
sessed as 1500 cases with 95% confidence interval, 25% rel-
ative accuracy and 10% elimination probability.
Obtaining Qazvin university ethics committee permis-
sion and consent from each case, 18 - 40 year-old sin-
gleton, less than 12-week of gestation parous mothers
were visited for their 1st prenatal care and included in
the study by accessible sampling. They were eliminated
if hemoglobinopathies (thalassemia and sickle cell), alco-
hol abuse, smoking, any cardiac disorders, chronic hyper-
tension, renal or pulmonary disorders and diabetes were
present.
At first, demographic data, including maternal age,
gestational age, height, education and parity were
recorded by a midwife in a questionnaire prepared by
the researcher at the medical center. The questionnaire’s
validity and reliability were assessed by content validity
and retesting, respectively. Pregnant mothers were re-
ferred to particular university-controlled laboratories in
Qazvin province. If this was done somewhere else, they
were omitted from the research. Hemoglobin (Hb) and
Hematocrit (Hct) recording in the questionnaire were
done after the tests. The mothers were followed up for
prenatal care according to the protocol released by the
ministry of medicine and health. Ferrous and multivita-
min supplementations were prescribed in each prenatal
visit and finally the mother was referred for termination
to Kowsar hospital, and if she were terminated some-
where else, she would be eliminated from the study. Other
elimination factors included: intrauterine fetal death,
fetal anomaly, amniotic fluid disorders, preterm labor,
placental abruption and placenta previa. If she had to be
terminated, due to high blood pressure and preeclamp-
sia, obstetrical data were recorded in the questionnaire.
Preeclampsia diagnosis was made according to William’s
obstetrics 2014 criteria (systolic blood pressure more than
140 and diastolic more than 90 mmhg with proteinuria,
which is an objective index, reflecting the vast endothelial
damage by the disorder, determined by more than 300
mg, 24 hours proteinuria or urinary creatinine ratio of
0.3 or more, or more than 30 mg proteinuria in a random
sample (1, 22)).
As in the study of Phaloprakarn, mothers were catego-
rized in three groups after data collection: Hb < 11, Hb ≥
12.49 and 11 ≤ Hb < 12.49, and based on Hct, two groups
were made Hct < 38% and Hct ≥ 38 (9). Data analyses
were performed by SPSS 16, chi-square (χ2) and T-test. Lo-
gistic regression was used for determining preeclampsia
relative risk. receiver operator characteristics (ROC) curve
and Youden’s Index were utilized to find the cut-off. P val-
ues of < 0.05 were considered significant.
4. Results
As shown in Figure 1, from the total of 1500 partici-
pants, 126 were eliminated and finally 1376 were studied.
The mean age was: 25.64 ± 5.58 years. In our re-
search, preeclampsia incidence was 5.1%, mean Hb 11.88
± 1.22 g/dL and mean Hct 35.58 ± 3.67%. Overall, there
were 660 nulliparous women, among which only 32 devel-
oped preeclampsia, and amongst 713 (51.9%) multiparous
women, 36 developed the disorder. This difference was not
significant. As a matter of education, 836 (60.1%) had not
graduated from high school, 443 (32.9 %) had high school
diploma and 95 (7.1%) had university degrees, which pre-
sented no significant difference in developing preeclamp-
sia. Mean body mass index was 24.68± 4.50 kg/m2; eight
participants (11.8%) were lower than 18.5 kg/m2, most of
them (31 cases) were placed in the higher than 25 kg/m2
group.
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1500 Women  
 
Women Were Inclusion  
N = 1376  
126 Women with Were Excluded (Intrauterine 
Fetal Death, Fetal Anomaly, Amniotic Fluid 
Disorders, Preterm Labor, Placental Abruption,
 Placenta Previa, Terminated Pregnancy
Somewhere Else and Laboratories Testes Was
 Done Somewhere Else)
Figure 1. Participation Flowchart
However no significant difference in developing
preeclampsia was found among them (Table 1).
Table 1. Demographic Characteristics of the Study Population by Preeclampsia
Variables Preeclampsia N =
68 (5.19%)
No Preeclampsia
N = 1308 (94.9%)
P Value




44 (66.7%) 792 (59.7%)
Diploma 17 (25.8%) 426 (33.3%)
University 5 (7.6%) 90 (7%)
BMI, Kg/m2 0.136
< 18.5 8 (11.8%) 79 (6%)
18.5 - 24.9 29 (42.6%) 663 (50.7%)




32 (47.1%) 628 (48.1%)
Multi-
parous
36 (52.9%) 677 (51.9%)
Mean Hb was 12.38 ± 1.69 g/dL in the preeclampsia
group and 11.8± 1.18 g/dL in non-preeclampsia group, with
a significant difference (P = 0.016).
Among 395 participants in Hb > 12.5 g/dL group, 43
(10.9%) developed preeclampsia. χ2 test, revealed a signif-
icant association between 1st trimester Hb and developing
preeclampsia (P < 0.001) (Table 2).
Estimated relative risk in high Hb group, compared
with normal Hb group, was 5.82 (3.14 - 10.78; CI 95%).
Mean Hct was 37.74± 5.15% in the preeclampsia group
and 35.45± 3.58 % in the preeclampsia group and 35.45±
3.58 % in the non-preeclampsia group (P = 0.001). Compar-
ing the two groups, relative risk was estimated as 7.41 (4.41
- 12.44; CI 95%).
Comparing high and normal Hb group with Bonfer-
roni’s correction, a significant difference was indicated (P
= 0.004), although Fisher’s exact test, could not demon-
strate a significant difference amongst the two groups in
developing preeclampsia (P = 0.091). The logistic regres-
sion model revealed, 1.43 increment, per one g/dL Hb in-
crease in developing preeclampsia (P = 0.001) (1.15 - 1.79, OR:
1.43; CI 95%).
We found no association between age, BMI and parity
with preeclampsia in this model.
The ROC curve has been utilized to determine an ap-
propriate cut-off for 1st trimester Hb and Hct. On the ba-
sis of Youden’s index, it was 12.65 g/dL for Hb. As indicated
by Table 3, with this cut-off, 1st trimester Hb test sensitivity
was calculated as 60% specificity 78%, positive predictive
value 13.07% and negative predictive value 97.30%, to pre-
















Figure 2. Receiver Operator Characteristics Curve of Hemoglobin During the First
Trimester of Pregnancy in Diagnosis of Preeclampsia (Area Under the Curve 0.65)
χ2 test demonstrated significant difference in 1st
trimester Hct in the preeclampsia group, compared with
the non-preeclampsia group (P < 0.001). Utilizing the ROC
curve (Figure 3), the appropriate cut-off for Hct was ob-
tained as 38.05%, therefore its sensitivity was calculated as
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Table 2. Frequently Distribution of the Studied Population in Three Groups of Hemoglobin and Preeclampsia
Preeclampsia Hb < 11 N = 228 11 < Hb < 12.49 N = 681 Hb > 12.5 N = 395 P Value
Yes 11 (4.4) 14 (2.1) 43 (10.9) < 0.001
No 218 (95.6) 667 (97.9) 352 (89.1) < 0.001
64%, specificity 80%, positive predictive value 15.14% and

















Figure 3. Receiver Operator Characteristics Curve of Hematocrit During the First
Trimester of Pregnancy for the Diagnosis of Preeclampsia (Area Under the Curve
0.69)
Table 3. Distribution of the Study Population by Preeclampsia and Cutoff Point of
Hemoglobin and Hematocrit
Variables Preeclampsia No preeclampsia P Value
Hemoglobin < 0.001
< 12.6 27 (40.3) 971 (78.5)
> 12.6 40 (59.7) 266 (21.5)
Hematocrit < 0.001
< 38.05 24 (35.8) 996 (80.5)
> 38.05 43 (64.2) 241 (19.4)
5. Discussion
In this study, preeclampsia incidence was 5.1%. How-
ever, this incidence was 6.7% in Safavi’s study on 700,
18 - 35 years-old singleton pregnant women during year
2011 (9). This study revealed a significant difference be-
tween mean 1st trimester hemoglobin in preeclampsia and
non-preeclampsia group (P < 0.001). The same was also
demonstrated in Safavi’s study (P = 0.002) (9). In a re-
search about high 1st trimester Hb influence on pregnancy
outcome in 2008, Phaloprakarn suggested that it could
be significantly associated with preeclampsia (P < 0.001)
(16). Bouzari’s study was about the influence of 1st and
2nd trimester Hb on preeclampsia, which was found to be
higher in the high Hb group. (Mean: 12.82± 1.2 g/dL), com-
pared with the normal Hb group (mean: 12.3± 1.39 g/dL) (P
= 0.016) (17). Aghamohamadi studied high 1st trimester Hb
as a risk factor for preeclampsia, in 2011, where there were
14 patients with preeclampsia (2.75%) in the normal Hb
group and 21 (4.2%) in the high Hb group, with a significant
difference (P = 0.045) (23). All studied mentioned above,
are compatible with our research. This study also demon-
strated a higher Hct in the preeclampsia group (37.74 ±
5.15) compared with lower Hct in the non-preeclampsia
group (35.45 ± 3.58), with a significant difference (P <
0.001). In Safavi’s study mean Hct in the preeclampsia
group was 39.06±2.98 and in the non-preeclampsia group
37.77 ± 3.52. χ2 test showed a significant association be-
tween high 1st trimester Hct and preeclampsia develop-
ment (P = 0.001)(9). Bouzari’s study also revealed higher
mean 1st trimester Hct (37.30 ± 3.70) in the preeclampsia
group compared to the control group (36.54± 3.45), with
a significant difference (P = 0.021) (17). Both of these studies
were in agreement with our study. In this research, relative
risk of developing preeclampsia in the higher Hb group
(1st trimester Hb≥ 12.5 g/dL) compared to the normal Hb
group was calculated as 5.82 (3.14 - 10.78), which is compati-
ble with the calculated relative risk in Phalorakarn’s study
[3.8; CI: 95%, (2 - 7.1)] (16) and that of Safavi’s study [4.52;
CI: 95% (1.74 - 11.74)](9). Using logistic regression analy-
sis, Aghamohammadi demonstrated increased preeclamp-
sia relative risk [2.46; CI: 95% (1 - 6.9)] in the higher Hb
group (23). This study determined the relative risk of de-
veloping preeclampsia as 7.4 CI 95%, (4.41 - 12.44) in the
higher Hct group (Hct≥ 38%), which was calculated [3.54;
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CI: 95%, (1.65 - 7.58) in Safavi’s study (9). Hemoglobin and
Hct measurement are obtained from fresh whole blood,
which could be influenced by plasma volume with hydra-
tion or dehydration. In fact, for calculating the ratio of
erythrocyte volume to whole blood, Hct would be a more
valuable parameter than Hb (19). Inspite of our research,
Goudarzi presented more preeclampsia development with
lower 1st trimester Hb in 2012 (P = 0.024) (20). The re-
sult of Karaflahin’s study (24) was the same as Goudarzi’s
(20), therefore they recommended the necessity of family
planning preconception evaluation to reduce unfavorable
pregnancy outcomes (24). Jack’s study revealed no associa-
tion among blood indices, and pregnancy outcome, like-
wise there would be no significant difference in HB and
Hct of any of the three trimesters in relation to preeclamp-
sia (25). Hemoglobin and Hct increment in preeclampsia
could be the result of compensatory mechanisms of de-
oxygenation in plasma as a result of placental secretion
(21). Utilizing the ROC curve, our research revealed Hb
cut-off of 12.26 g/dL in the 1st trimester, which could be a
predictor of preeclampsia with 60% sensitivity, 78% speci-
ficity, 13.07% positive predictive value and 97.30% negative
predictive value. With Safavi’s study, the cut-off point was
12.5 g/dL with 85% sensitivity, 43.03% specificity, 9.63% pos-
itive predictive value and 97.57% negative predictive value
in preeclampsia prediction, which is compatible with our
results (9). Our study showed the 1st trimester Hct cut-
off of 38.05%. With 64% sensitivity, 80% specificity, 15.14%
positive predictive value and 97.65% negative predictive
value in predicting preeclampsia, likewise Mello’s study
was in agreement with ours in reporting 1st trimester Hct
role in early preeclampsia prediction with 63% sensitiv-
ity, 90% specificity 36% positive predictive value and 92%
negative predictive value (26). Safavi’s study calculated 1st
trimester Hct cut-off of 38% with 77.5% sensitivity, 50.7%
specificity, 10.1% positive predictive value and 96.95% neg-
ative predictive value in preeclampsia prediction. The two
mentioned studies were compatible with ours. It appears
that 1st trimester Hb and Hct could be an alarming sign
for developing preeclampsia in the next conception weeks,
therefore by early high risk population detection, prena-
tal care could be managed more frequently and more ac-
curately and more precisely in order to prevent fetal, in-
fantile and maternal complications. This research demon-
strated the association of 1st trimester Hb and Hct incre-
ment with preeclampsia development. According to the
results, Hb≥ 12.5 g/dL and Hct≥ 38.05 in the 1st trimester
indicate high risk and necessitate, more frequent prenatal
care. More widespread researches, including the associa-
tion of routine prenatal tests and supplements like iron,
calcium, magnesium and zinc with preeclampsia is recom-
mended.
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